Advertisement
CI vs CVS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a Buy and CVS is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 2 FA rating(s) are green whileCVS’s FA Score has 3 green FA rating(s).
- CI’s FA Score: 2 green, 3 red.
- CVS’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 8 TA indicator(s) are bullish while CVS’s TA Score has 6 bullish TA indicator(s).
- CI’s TA Score: 8 bullish, 3 bearish.
- CVS’s TA Score: 6 bullish, 4 bearish.
Price Growth
CI (@Publishing: Books/Magazines) experienced а -1.14% price change this week, while CVS (@Publishing: Books/Magazines) price change was +2.59% for the same time period.
The average weekly price growth across all stocks in the @Publishing: Books/Magazines industry was +1.69%. For the same industry, the average monthly price growth was +7.98%, and the average quarterly price growth was -7.90%.
Reported Earning Dates
CI is expected to report earnings on Oct 30, 2025.
CVS is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Publishing: Books/Magazines (+1.69% weekly)The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.
| CI | CVS | CI / CVS | |
| Capitalization | 80.3B | 92.8B | 87% |
| EBITDA | N/A | 14.2B | - |
| Gain YTD | 10.018 | 68.544 | 15% |
| P/E Ratio | 16.50 | 20.38 | 81% |
| Revenue | 259B | 387B | 67% |
| Total Cash | 5.04B | 14.2B | 35% |
| Total Debt | 30.8B | 82.7B | 37% |
CI | CVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 28 Undervalued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 33 | 75 | |
SMR RATING 1..100 | 61 | 82 | |
PRICE GROWTH RATING 1..100 | 60 | 9 | |
P/E GROWTH RATING 1..100 | 92 | 9 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (18) in the Drugstore Chains industry is in the same range as CI (28) in the Managed Health Care industry. This means that CVS’s stock grew similarly to CI’s over the last 12 months.
CI's Profit vs Risk Rating (33) in the Managed Health Care industry is somewhat better than the same rating for CVS (75) in the Drugstore Chains industry. This means that CI’s stock grew somewhat faster than CVS’s over the last 12 months.
CI's SMR Rating (61) in the Managed Health Care industry is in the same range as CVS (82) in the Drugstore Chains industry. This means that CI’s stock grew similarly to CVS’s over the last 12 months.
CVS's Price Growth Rating (9) in the Drugstore Chains industry is somewhat better than the same rating for CI (60) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than CI’s over the last 12 months.
CVS's P/E Growth Rating (9) in the Drugstore Chains industry is significantly better than the same rating for CI (92) in the Managed Health Care industry. This means that CVS’s stock grew significantly faster than CI’s over the last 12 months.
| CI | CVS | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 59% | 4 days ago 77% |
| Stochastic ODDS (%) | 4 days ago 62% | 4 days ago 62% |
| Momentum ODDS (%) | 4 days ago 65% | 4 days ago 73% |
| MACD ODDS (%) | 4 days ago 60% | 4 days ago 63% |
| TrendWeek ODDS (%) | 4 days ago 56% | 4 days ago 60% |
| TrendMonth ODDS (%) | 4 days ago 64% | 4 days ago 57% |
| Advances ODDS (%) | 13 days ago 65% | 4 days ago 63% |
| Declines ODDS (%) | 5 days ago 60% | 8 days ago 59% |
| BollingerBands ODDS (%) | 4 days ago 65% | 4 days ago 65% |
| Aroon ODDS (%) | 4 days ago 61% | 4 days ago 52% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PPH | 88.88 | 0.48 | +0.54% |
| VanEck Pharmaceutical ETF | |||
| ROMO | 32.96 | N/A | N/A |
| Strategy Shares Nwfnd/RSlv Rbt Mmt ETF | |||
| BMN | 24.22 | N/A | N/A |
| BlackRock 2037 Municipal Target Term Trust | |||
| FNDE | 34.44 | -0.08 | -0.23% |
| Schwab Fundamental Emerging MarketsEqETF | |||
| SIXG | 57.47 | -1.34 | -2.28% |
| Defiance Connective Technologies ETF | |||